|
|
|
| Medication for attention-deficit/hyperactivity disorder |
| YANG Binrang |
| Department of Child Care, Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China |
|
|
|
|
Abstract Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders with a chronic course. Its core characteristics are inattention, hyperactivity/impulsivity, with comorbid other neurodevelopmental or psychiatric disorders. ADHD can cause negative impacts on the academic, interpersonal, professional, self-evaluation/self-esteem and other functions of patients, which brings heavy economic and mental burdens to patients, families and society. Evidence supports the efficacy and safety of short-term medication, but there is a lack of randomized controlled studies on its long-term efficacy. ADHD practice guidelines recommend regular evaluation to determine whether there is a need for continued treatment.
|
|
|
|
|
|
|
|
|
